Pfizer Inc.

NYSE:PFE

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

Location

United States

Market Cap

USD 136.28 B

Share Price

USD 23.97

Avg Daily Volume

52,794,624

Change (1 day)

0.38%

Change (1 year)

-13.59%

Change (YTD)

-9.65%

Pfizer Inc. Total Liabilities for the year ending December 31, 2024: USD 124.90 B

Pfizer Inc. Total Liabilities is USD 124.90 B for the year ending December 31, 2024, a -8.97% change year over year. Total liabilities are the total amount of a company's debts and other obligations.

Pfizer Inc. Total Liabilities for the year ending December 31, 2023 was USD 137.21 B, a 35.47% change year over year.
Pfizer Inc. Total Liabilities for the year ending December 31, 2022 was USD 101.29 B, a -2.62% change year over year.
Pfizer Inc. Total Liabilities for the year ending December 31, 2021 was USD 104.01 B, a 14.61% change year over year.
Pfizer Inc. Total Liabilities for the year ending December 31, 2020 was USD 90.76 B, a -12.77% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Total Liabilities	Shareholders' Equity	Cash and Short-Term Investments	Receivables

NYSE: PFE

Pfizer Inc.

CEO	Dr. Albert Bourla D.V.M., Ph.D.
IPO Date	June 1, 1972
Location	United States
Headquarters	235 East 42nd Street
Employees	81,000
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies

Description

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.